Brief fixation enables same-day breast cancer diagnosis with reliable assessment of hormone receptors, E-cadherin and HER2/Neu

Autor: J.P. Bulte, Peter Bult, Hans de Wilt, Iris D. Nagtegaal, Hanneke Braam, Oliver B. A. Boelens, Patricia van Cleef, Margrethe Schlooz-Vries, Annelies Werner, Yvonne Jacobs, Altuna Halilovic
Rok vydání: 2017
Předmět:
0301 basic medicine
Pathology
Time Factors
Tissue Fixation
Receptor
ErbB-2

medicine.medical_treatment
HER2/neu
Workflow
Tumours of the digestive tract Radboud Institute for Health Sciences [Radboudumc 14]
0302 clinical medicine
Tumours of the digestive tract Radboud Institute for Molecular Life Sciences [Radboudumc 14]
skin and connective tissue diseases
In Situ Hybridization
Fluorescence

Neoadjuvant therapy
Netherlands
Fixation (histology)
Aged
80 and over

Academic Medical Centers
Women's cancers Radboud Institute for Molecular Life Sciences [Radboudumc 17]
medicine.diagnostic_test
biology
General Medicine
Middle Aged
Cadherins
Immunohistochemistry
Receptors
Estrogen

Hormone receptor
030220 oncology & carcinogenesis
Female
Receptors
Progesterone

Adult
medicine.medical_specialty
Breast Neoplasms
Pathology and Forensic Medicine
03 medical and health sciences
Breast cancer
Antigens
CD

Predictive Value of Tests
Biopsy
Progesterone receptor
Biomarkers
Tumor

medicine
Humans
Aged
business.industry
Reproducibility of Results
medicine.disease
030104 developmental biology
biology.protein
Biopsy
Large-Core Needle

business
Zdroj: Journal of Clinical Pathology : the Journal of the Association of Clinical Pathologists, 70, 9, pp. 781-786
Journal of Clinical Pathology : the Journal of the Association of Clinical Pathologists, 70, 781-786
ISSN: 0021-9746
DOI: 10.1136/jclinpath-2017-204362
Popis: AimsPreoperative core needle biopsy (CNB) is commonly used to confirm the diagnosis of breast cancer. For treatment purposes and for determining histological type, especially in case of neoadjuvant therapy, oestrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor 2 (HER2) status and E-cadherin assessments are crucial. Considering the increasing demand for same-day diagnosis of breast lesions, an accelerated method of CNB processing was developed, in which the tissue fixation time is radically reduced.MethodsTo determine whether short fixation time frustrates assessment of ER, PR and E-cadherin immunohistochemistry (IHC) and HER2 fluorescence in situ hybridisation (FISH), 69 consecutive patients with 70 invasive breast carcinomas were included through the same-day diagnostics programme of breast lesions of the Radboud university medical center and the hospital Pantein. IHC for ER, PR and E-cadherin and HER2 FISH were compared between CNBs fixed for approximately 60–90 min and traditionally fixed resection specimens.ResultsOverall agreement between CNBs and resection specimens was 98.6% for ER (pConclusionsHormone receptors and E-cadherin IHC and HER2 FISH are highly comparable between briefly fixed CNBs and the corresponding traditionally fixed resection specimens, and can therefore reliably be used in the daily clinical practice of same-day diagnostics of breast cancer.
Databáze: OpenAIRE